UCB Sa operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares UCB Sa with three other
pharmaceutical manufacturers in Europe:
Lonza Group AG
sales of 4.13 billion Swiss Francs [US$4.37 billion]
of which 54%
was Specialty Ingredients),
(241.48 billion Russian Rubles [US$4.07 billion]
of which 81%
was Distribution), and
Stada Arzneimittel AG
based in Germany
(2.14 billion Euro [US$2.50 billion]
of which 60%
UCB Sa reported sales of 4.18 billion Euro (US$4.88 billion)
December of 2016.
increase of 7.8%
versus 2015, when the company's sales were 3.88 billion Euro.